Glaxo Smith Kline
- 54.91 EGP
- 2.44
- 4.65%
Glaxo Smith Kline Stock Overview
View Company ProfileStock Summary
| Last Price (EGP) | 54.91 |
| Prev. Close | 52.470 |
| Day Range | 52.50 - 54.98 |
| 52WK range | |
| Turnover (M EGP) | 14.79 |
| Volume (M) | 0.27 |
| Number of Trades | 585 |
| Market Cap (M EGP) | 4,381.99 |
| Change in Market Cap (M EGP) | |
| VWAP (EGP) | 54.91 |
| EPS (TTM) | -- |
| EX-Dividend Date | |
| Dividend | |
| Dividend Yield (%) | |
| Beta | |
| 30D Avg Volume | |
| 30D Avg Turnover(M EGP) | |
| Outstanding Shares | |
| Free Float Shares | |
| Free Float % |
Stock Performance
Stock Highlights
| Highest Market Cap | |
| Date of Highest Mkt. Cap | |
| Lowest Market Cap | |
| Date of Lowest Mkt. Cap |
Earnings Progress
News
More Company News
GSK Egypt’s consolidated net profits shrink to EGP...
Cairo - Egypt: GlaxoSmithKline (GSK Egypt) generated lower consolidated net profits after tax at EGP 65.05 million as of 30 June 2025, compared to EGP...
GSK Egypt posts EGP 106m consolidated profits in 9M-24
Cairo – Mubasher: GlaxoSmithKline (GSK Egypt) registered an annual growth in consolidated net profit after tax to EGP 105.82 million...
GSK Egypt’s net profits hike in H1-24
Cairo – Mubasher: GlaxoSmithKline (GSK Egypt) posted consolidated net profits amounting to EGP 92.55 million in the first half (H1)...
GSK Egypt turns to loss in Q1-24
Cairo – Mubasher: GlaxoSmithKline (GSK Egypt) turned to a consolidated net loss of EGP 8.98 million in the first quarter (Q1) of 2024,...
GSK Egypt obtains shareholders’ nod for 2023 cash dividends
Cairo – Mubasher: GlaxoSmithKline (GSK Egypt) plans to disburse cash dividends valued at EGP 0.75 per share for 2023, according to a bourse...
